Viewing StudyNCT01399125



Ignite Creation Date: 2024-05-05 @ 11:43 PM
Last Modification Date: 2024-10-26 @ 10:38 AM
Study NCT ID: NCT01399125
Status: COMPLETED
Last Update Posted: 2014-08-04
First Post: 2011-07-19

Brief Title: A 24-Week Efficacy Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimers Disease
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Alzheimers Disease
Keywords:
Name View
Alzheimers View
Rivastigmine View
Patch View
Dementia View